Neuropeptidni FF receptori[1] su članovi familije G-protein spregnutih receptora, integralnih membranskih proteina koji vezuju modulatorne neuropeptide bola AF i FF.[2] Za ove neuropeptide se smatra da učestvuju u modulaciji funkcija opioidnog receptora u mozgu i kičmenoj moždini, i da imaju bilo sposobnost umanjenja ili povećanja dejstva receptora u zavisnosti od tipa tkiva u kome su oslobođeni, što odražava kompleksnu ulogu neuropeptida FF u odgovoru na bol.[3][4][5][6][7]
- Neuropeptid AF
- Neuropeptid FF
Antagonisti
uredi
Literatura
uredi
- ↑ Parker RM, Copeland NG, Eyre HJ, Liu M, Gilbert DJ, Crawford J, Couzens M, Sutherland GR, Jenkins NA, Herzog H (2000). „Molecular cloning and characterisation of GPR74 a novel G-protein coupled receptor closest related to the Y-receptor family”. Brain Res. Mol. Brain Res. 77 (2): 199–208. DOI:10.1016/S0169-328X(00)00052-8. PMID 10837915.
- ↑ Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmidt DB, Buckley PT, Dytko GM, Murdock PR, Milligan G, Groarke DA, Tan KB, Shabon U, Nuthulaganti P, Wang DY, Wilson S, Bergsma DJ, Sarau HM (2000). „Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor”. J. Biol. Chem. 275 (34): 25965–71. DOI:10.1074/jbc.M004515200. PMID 10851242.
- ↑ Yang HY, Iadarola MJ (May 2006). „Modulatory roles of the NPFF system in pain mechanisms at the spinal level”. Peptides 27 (5): 943–52. DOI:10.1016/j.peptides.2005.06.030. PMID 16443306.
- ↑ Roumy M, Lorenzo C, Mazères S, Bouchet S, Zajac JM, Mollereau C (March 2007). „Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity”. The Journal of Biological Chemistry 282 (11): 8332–42. DOI:10.1074/jbc.M606946200. PMID 17224450.
- ↑ Yang HY, Tao T, Iadarola MJ (February 2008). „Modulatory role of neuropeptide FF system in nociception and opiate analgesia”. Neuropeptides 42 (1): 1–18. DOI:10.1016/j.npep.2007.06.004. PMID 17854890.
- ↑ Betourne A, Familiades J, Lacassagne L, Halley H, Cazales M, Ducommun B, Lassalle JM, Zajac JM, Frances B (November 2008). „Decreased motivational properties of morphine in mouse models of cancerous- or inflammatory-chronic pain: implication of supraspinal neuropeptide FF(2) receptors”. Neuroscience 157 (1): 12–21. DOI:10.1016/j.neuroscience.2008.08.045. PMID 18804517.
- ↑ Cline MA, Mathews DS (2008). „Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands”. General and Comparative Endocrinology 159 (2-3): 125–9. DOI:10.1016/j.ygcen.2008.09.001. PMID 18823989.
- ↑ Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M, Parmentier M, Zajac JM (2002). „Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists”. Eur. J. Pharmacol. 451 (3): 245–56. DOI:10.1016/S0014-2999(02)02224-0. PMID 12242085.
- ↑ Fang Q, Guo J, He F, Peng YL, Chang M, Wang R (September 2006). „In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist”. Peptides 27 (9): 2207–13. DOI:10.1016/j.peptides.2006.04.002. PMID 16762456.
- ↑ Fang Q, Wang YQ, He F, Guo J, Guo J, Chen Q, Wang R (April 2008). „Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist”. Regulatory Peptides 147 (1-3): 45–51. DOI:10.1016/j.regpep.2007.12.007. PMID 18276024.
- ↑ Wang YQ, Guo J, Wang SB, Fang Q, He F, Wang R (July 2008). „Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice”. Peptides 29 (7): 1183–90. DOI:10.1016/j.peptides.2008.02.016. PMID 18406009.
Spoljašnje veze
uredi
